605 related articles for article (PubMed ID: 30905657)
21. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
Georgiadis D; Yiotakis A
Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
[TBL] [Abstract][Full Text] [Related]
22. Expression of ADAMs and their inhibitors in sputum from patients with asthma.
Paulissen G; Rocks N; Quesada-Calvo F; Gosset P; Foidart JM; Noel A; Louis R; Cataldo DD
Mol Med; 2006; 12(7-8):171-9. PubMed ID: 17088949
[TBL] [Abstract][Full Text] [Related]
23. Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats.
Cal S; Arguelles JM; Fernandez PL; López-Otín C
J Biol Chem; 2001 May; 276(21):17932-40. PubMed ID: 11279086
[TBL] [Abstract][Full Text] [Related]
24. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member.
Matthews RT; Gary SC; Zerillo C; Pratta M; Solomon K; Arner EC; Hockfield S
J Biol Chem; 2000 Jul; 275(30):22695-703. PubMed ID: 10801887
[TBL] [Abstract][Full Text] [Related]
25. The exon/intron organization and chromosomal mapping of the mouse ADAMTS-1 gene encoding an ADAM family protein with TSP motifs.
Kuno K; Iizasa H; Ohno S; Matsushima K
Genomics; 1997 Dec; 46(3):466-71. PubMed ID: 9441751
[TBL] [Abstract][Full Text] [Related]
26. ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.
Yang CY; Chanalaris A; Troeberg L
Osteoarthritis Cartilage; 2017 Jul; 25(7):1000-1009. PubMed ID: 28216310
[TBL] [Abstract][Full Text] [Related]
27. Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases.
Pluda S; Mazzocato Y; Angelini A
Front Mol Biosci; 2021; 8():703715. PubMed ID: 34368231
[TBL] [Abstract][Full Text] [Related]
28. The ADAM metalloproteinases.
Edwards DR; Handsley MM; Pennington CJ
Mol Aspects Med; 2008 Oct; 29(5):258-89. PubMed ID: 18762209
[TBL] [Abstract][Full Text] [Related]
29. Evolutionary divergence and functions of the ADAM and ADAMTS gene families.
Brocker CN; Vasiliou V; Nebert DW
Hum Genomics; 2009 Oct; 4(1):43-55. PubMed ID: 19951893
[TBL] [Abstract][Full Text] [Related]
30. Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain.
Sagane K; Ohya Y; Hasegawa Y; Tanaka I
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):93-8. PubMed ID: 9693107
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification.
Du Y; Gao C; Liu Z; Wang L; Liu B; He F; Zhang T; Wang Y; Wang X; Xu M; Luo GZ; Zhu Y; Xu Q; Wang X; Kong W
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2580-8. PubMed ID: 22995515
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
33. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.
Dickinson SC; Vankemmelbeke MN; Buttle DJ; Rosenberg K; Heinegård D; Hollander AP
Matrix Biol; 2003 May; 22(3):267-78. PubMed ID: 12853037
[TBL] [Abstract][Full Text] [Related]
34. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration.
Zigrino P; Steiger J; Fox JW; Löffek S; Schild A; Nischt R; Mauch C
J Biol Chem; 2007 Oct; 282(42):30785-93. PubMed ID: 17704059
[TBL] [Abstract][Full Text] [Related]
35. (Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T; Jorissen E; Reiss K; Hartmann D
Birth Defects Res C Embryo Today; 2006 Mar; 78(1):24-46. PubMed ID: 16622847
[TBL] [Abstract][Full Text] [Related]
36. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
Schwettmann L; Wehmeier M; Jokovic D; Aleksandrova K; Brand K; Manns MP; Lichtinghagen R; Bahr MJ
J Hepatol; 2008 Aug; 49(2):243-50. PubMed ID: 18490073
[TBL] [Abstract][Full Text] [Related]
37. Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat.
Espey LL; Yoshioka S; Russell DL; Robker RL; Fujii S; Richards JS
Biol Reprod; 2000 Apr; 62(4):1090-5. PubMed ID: 10727282
[TBL] [Abstract][Full Text] [Related]
38. Anti-angiogenic properties of ADAMTS-4 in vitro.
Hsu YP; Staton CA; Cross N; Buttle DJ
Int J Exp Pathol; 2012 Feb; 93(1):70-7. PubMed ID: 22264287
[TBL] [Abstract][Full Text] [Related]
39. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
[TBL] [Abstract][Full Text] [Related]
40. ADAMs in cancer cell proliferation and progression.
Mochizuki S; Okada Y
Cancer Sci; 2007 May; 98(5):621-8. PubMed ID: 17355265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
